Filing summary
Important entity and period clarification: The supplied filing is Tortoise Acquisition Corp.’s Form 10-K for the fiscal year ended December 31, 2019—not a Hyliion Holdings Corp. filing or a standalone 2019 Q4 report. Tortoise was a SPAC, not an operating business; it reported no operating revenue and was searching for a business-combination target.
Business context and reporting period
Tortoise completed its IPO on March 4, 2019, raising approximately $233.0 million from public units and $6.66 million from private-placement warrants. Approximately $233.0 million was placed in a trust account. At year-end, the company said it was evaluating acquisition opportunities, with no definitive business-combination agreement in place. Its stated focus was energy, though it could pursue targets in other industries.
The comparable prior-period results cover only November 7 through December 31, 2018, from inception, and are not a full-year comparison. The filing is audited and was signed March 23, 2020.
Key financial metrics
| Metric | 2019 / December 31, 2019 |
|---|---|
| Operating revenue | None; the company had not commenced operations. |
| Investment income | $3.86 million, earned on trust-account investments. |
| Operating loss | $764,782, including general and administrative, related-party administrative, and franchise-tax expenses. |
| Income tax expense | $768,006. |
| Net income | $2.32 million, versus a $591 net loss from inception through December 31, 2018. |
| Cash flows | Operating cash used: $1.25 million; investing cash used: $232.20 million; financing cash provided: $234.36 million; net increase in cash: $916,226. |
| Cash and liquidity | $916,226 cash outside the trust; $236.05 million in trust-account investments. Management also reported approximately $3.0 million of trust investment income available for taxes, subject to the filing’s stated restrictions. |
| Debt and obligations | No long-term debt or lease obligations at year-end. A roughly $580,000 sponsor loan was repaid in March 2019. Liabilities included $8.13 million of deferred underwriting commissions payable upon a completed business combination and $150,000 of deferred legal fees. |
| Equity and redemption | $5.00 million of stockholders’ equity; 22.37 million Class A shares, valued at $10.00 per share, were classified as temporary equity due to possible redemption. |
Profitability and margins from operating activity are not meaningful because the company had no operating revenue; 2019 net income primarily reflected trust-account investment income.
Material changes versus the prior comparable period
The company moved from formation-stage activity in late 2018 to completing its IPO and holding trust investments in 2019. Net income of $2.32 million in 2019 primarily reflected $3.86 million of investment income, while the prior inception period recorded a $591 loss. Cash, trust investments, redeemable public shares, and deferred IPO-related obligations arose in connection with the IPO. Because the prior period was less than two months, it is not directly comparable to the 2019 fiscal year.
Outlook, risks, contingencies, and unusual items
- Combination deadline and going concern: The company had 24 months from its March 4, 2019 IPO closing—through March 4, 2021—to complete a business combination. If unsuccessful, it would wind up and redeem public shares, subject to creditor claims and applicable law. Management and the auditor stated that mandatory liquidation raised substantial doubt about the company’s ability to continue as a going concern; the financial statements were not adjusted for a possible liquidation.
- Potential financing: Atlas Point Fund agreed to purchase up to $150 million of forward-purchase securities at the business-combination closing, but its purchase required its discretionary consent and other conditions. The funding was therefore not assured. Additional financing might be needed, potentially through debt or dilutive equity.
- Redemptions and dilution: Public stockholders could redeem shares in connection with a combination. High redemptions could undermine closing conditions or require additional financing. Founder shares could convert into 20% of specified post-IPO shares, subject to terms and exclusions; warrants and other issuances could further dilute holders.
- Trust-account and creditor exposure: The trust could be subject to creditor claims, potentially reducing funds available for a combination or redemption. The sponsor’s indemnity is limited and its ability to pay was not verified. The filing also notes potential stockholder liability for claims up to distributions received in certain liquidation circumstances.
- Governance and conflicts: Sponsor and management interests, competing obligations to Tortoise-affiliated funds, potential affiliated transactions, and limited public-stockholder voting rights could affect target selection and transaction terms. The sponsor received $10,000 per month for administrative services, and out-of-pocket expenses could be reimbursed without a stated cap.
- COVID-19: The filing identified the emerging coronavirus outbreak as a risk that could delay target discussions, due diligence, financing, or completion of a business combination.
- Other unusual items: The company reported no material litigation, no off-balance-sheet arrangements, and no long-term debt at year-end. The independent auditor gave an unqualified opinion on the financial statements but highlighted the going-concern uncertainty. Management concluded disclosure controls were effective; no internal-control attestation was included.
Most important facts for investors to verify
- Confirm the issuer: this filing is for Tortoise Acquisition Corp., not Hyliion Holdings Corp.; confirm whether a separate Hyliion filing was intended.
- Verify any subsequent business-combination, liquidation, or other corporate developments after the filing’s March 2020 signing date.
- Check whether Atlas Point’s forward-purchase commitment was consented to and funded, and review any additional financing and resulting dilution.
- Review the trust balance, redemptions, deferred underwriting commissions, and any creditor claims when assessing cash available to a transaction or shareholders.
- Assess the full warrant, founder-share conversion, redemption, and voting terms, including their potential effects on ownership and transaction outcomes.